Personalis, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Personalis, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $929.00K, a 48.88% increase year-over-year.
- Personalis, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $617.00K, a 142.91% increase year-over-year.
- Personalis, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- Personalis, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $624.00K, a 96.85% increase year-over-year.
- Personalis, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.24M, a 117.34% increase from fiscal 2024.
- Personalis, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $571.00K, a 57.51% decline from fiscal 2023.
- Personalis, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.34M, a 7.63% decline from fiscal 2022.
- Personalis, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.46M, a 38.87% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $929.00K 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.24M 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | |
| 2025-06-30 | $624.00K 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $571.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | |
| 2024-06-30 | $317.00K 10-Q · filed 2025-08-05 | |
| 2023-12-31 | $435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.34M 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | |
| 2023-06-30 | $909.00K 10-Q · filed 2024-08-07 | |
| 2022-12-31 | $481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.46M 10-K · filed 2024-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | |
| 2022-06-30 | $974.00K 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.38M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | |
| 2021-06-30 | $1.19M 10-Q · filed 2022-08-03 | |
| 2020-12-31 | $784.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.42M 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2020-06-30 | $631.00K 10-Q · filed 2021-08-04 | |
| 2019-12-31 | $684.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |